1 / 23

Enrico Tortoli Florence – Italy Presented at 34° ICAAC – Chicago, September 14, 2003

Role of phenotypic and genotypic investigations for the identification of non-tuberculous mycobacteria. Enrico Tortoli Florence – Italy Presented at 34° ICAAC – Chicago, September 14, 2003. 1990. 1995. 2000. The rise of mycobacterial species. The rise of mycobacterial species.

angeni
Download Presentation

Enrico Tortoli Florence – Italy Presented at 34° ICAAC – Chicago, September 14, 2003

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Role of phenotypic and genotypic investigations for the identification of non-tuberculous mycobacteria Enrico Tortoli Florence – Italy Presented at 34° ICAAC – Chicago, September 14, 2003

  2. 1990 1995 2000 The rise of mycobacterial species

  3. The rise of mycobacterial species • 94 officially recognized nontuberculous mycobacterial (NTM) species • On average 3 new species/yr described in the last 14 years • A large number of “new” mycobacterial sequences are piling up in GenBank

  4. 10 Slow growers

  5. 10 Slow growers

  6. 10 Slow growers

  7. 10 Rapid growers

  8. 10 Rapid growers

  9. NTM, frequently raised criticisms • NTN differentiation is unnecessary, only their distinction from M. tuberculosis complex is of importance • The NTM are rarely clinically significant • In the cases in which NTM are clinically significant their identification at species level is of little use for the clinician

  10. NTM, frequently raised criticisms. Replay 1 • NTN differentiation is unnecessary, only their distinction from M. tuberculosis complex is of importance • The identification of “new” NTM is essential to enlarge the current poor knowledge of such organisms and, first of all, of their clinical relevance

  11. NTM, frequently raised criticisms. Replay 2 • The NTM are rarely clinically significant • Among NTM isolated from human samples, for 5 species only the involvement in disease has never been proved

  12. NTM, frequently raised criticisms. Replay 3 • In the cases in which NTM are clinically significant their identification at species level is of little use for the clinician • Several NTM differ for virulence • Some NTM are preferentially involved in specific pathologies • Various NTM are characterized by different susceptibility pattern

  13. Phenotypic identification methods • Conventional approach • Biochemical tests • Cultural tests • Selective inhibition tests • Lipid approach • Thin layer chromatography • Gas-chromatography • High performance liquid chromatography

  14. Phenotypic identification methods • Conventional approach • Biochemical tests • Cultural tests • Selective inhibition tests • Lipid approach • Thin layer chromatography • Gas-chromatography • High performance liquid chromatography

  15. Phenotypic identification methods • Conventional approach • Biochemical tests • Cultural tests • Selective inhibition tests • Lipid approach • Thin layer chromatography • Gas-chromatography • High performance liquid chromatography

  16. 10 Genotypic identification methods • Nucleic acid probes • PCR restriction analysis • Genetic sequencing of conserved regions

  17. Limits of conventional methods • Conventional approach worked apparently well until the number of species remained limited • It run into problems with the expansion of the number of species • Need of larger panels of tests • Still insufficient information available for many species • Previously disregarded problems emerged • Low reproducibility of several tests • Biological variability of the strains • Misidentification of strains belonging to new species as variants of well established ones • Time consumption

  18. Limitations of lipid methods • Culture-dependent • TLC and GLC • Large clusters of species exist sharing the same pattern • HPLC • Emergence, among new mycobacteria, of species with similar profiles (rapid growers)

  19. Limitations of genetic methods • DNA probes • Highly reliable but available for common species only • PRA • Unidentified strains with patterns overlapping to the ones of well defined species • Species with multiple patterns (up to 8) • Genetic sequencing (16S rDNA) • Species with overlapping sequences • Species with multiple sequevars • Poor quality control of major databases

  20. identification + identification new sequence Identification for diagnostic purpose DNA probe 16S rDNA sequence

  21. Description of new species, minimal standard • Major biochemical and cultural features • Lipid structure • TLC • GLC • HPLC • Full 16S rDNA sequence

  22. Conclusions • Genetic sequencing of 16S rDNA is at present the only method that, even when used alone, provides reliable identifications • Identifications emerging from PRA of 65kD hsp are satisfactory but many are the species whose pattern has been not yet determined • Among lipid investigations the HPLC is the one with higher discriminatory power, species do exist whose identification cannot be determined • With conventional tests a correct identification is achievable for “classical” mycobacteria only; selected tests may help in resolving ambiguities due to overlapping of genetic characters

More Related